EX-23.1 3 nxtc-20231231xex23d1.htm EX-23.1

Exhibit 23.1

​

Consent of Independent Registered Public Accounting Firm

​

We consent to the incorporation by reference in the following Registration Statements:

​

| (1) | Registration Statement (Form S-8 No. 333-231438) pertaining to the NextCure, Inc. 2019 Employee Stock Purchase Plan,

​

| (2) | Registration Statement (Form S-8 No. 333-231436) pertaining to the NextCure, Inc. 2015 Omnibus Incentive Plan and the NextCure, Inc. 2019 Omnibus Incentive Plan,

​

| (3) | Registration Statement (Form S-8 No. 333-260776) pertaining to the NextCure, Inc. 2019 Employee Stock Purchase Plan,

​

| (4) | Registration Statement (Form S-8 No. 333-260779) pertaining to the NextCure, Inc. 2019 Omnibus Incentive Plan,

​

| (5) | Registration Statement (Form S-8 No. 333-273735) of NextCure, Inc.,

​

| (6) | Registration Statement (Form S-3 No. 333-241706) of NextCure, Inc., and

​

| (7) | Registration Statement (Form S-3 No. 333-273723) of NextCure, Inc.

​

of our report dated March 21, 2024, with respect to the financial statements of NextCure, Inc. included in this Annual Report (Form 10-K) of NextCure, Inc. for the year ended December 31, 2023.

​

​

​ | ​
/s/ Ernst & Young LLP | ​
​ | ​
Baltimore, Maryland | ​
March 21, 2024 | ​

​